We previously demonstrated that acidic bile activates NF-jB, deregulating the expression of oncogenic miRNA markers, in pre-malignant murine laryngopharyngeal mucosa.
between acidic bile or GDF and early pre-neoplastic events in laryngopharyngeal mucosa. [8] [9] [10] Specifically, the combination of bile and acid (pH ≤4.0) constitutively activates NF-jB, up-regulating the expression of cancer-related genes and deregulating the expression of oncogenic miRNA markers, such as "oncomirs" miR-21, miR-192, miR-155 and "tumour suppressors" miR-34a, miR-375 and miR-451a, in pre-malignant lesions of murine laryngopharyngeal mucosa. 9, 10 Here, we describe an in vitro model exploring repetitive exposures of normal human hypopharyngeal cells to acidic bile, with and without BAY 11-7082, a pharmacologic inhibitor of NF-jB. 11 We hypothesize that NF-jB inhibitor is capable of preventing the acidic bile-induced up-regulation of "oncomirs" miR-21, miR-155 and miR-192 and down-regulation of "tumour suppressor" miR-34a, miR-375
and miR-451a, previously associated with laryngopharyngeal cancer, [12] [13] [14] [15] [16] [17] providing insight into interactions of transcriptionally active NF-jB with cancer-related miRNA markers.
MicroRNA (miRNA) molecules have been considered to play an important role in both inflammation and cancer, 18 modulating the expression of genes by causing target mRNA degradation or inhibiting their translation. 19 Specifically, some miRNAs, such as "oncomirs"
and "tumour suppressor" miRNAs, show altered expression levels in tumour cells compared to normal cells (up-regulated or down-regulated) and are capable of contributing to carcinogenesis, demonstrating a significant regulating role in the multistep process of cancer initiation and progression. 20 Previous studies have demonstrated that deregulation of "oncomirs" miR-21, miR-155, miR-192 and tumour suppressor miR-375, miR-451a and miR-34a is associated with laryngopharyngeal cancer. [12] [13] [14] [15] [16] [17] Moreover, an independent association has been demonstrated between NF-jB activation and up-regulation of oncogenic miR-21 and/or down-regulation of tumour suppressor miR-34a and miR-451a. [21] [22] [23] BAY 11-7082 was selected as a reliable inhibitor of NF-jB pathway that has been widely used in many studies exploring the effect of NF-jB. 11, 24, 25 It has been suggested that BAY 11-7082 offers the most rapid and potent antitumour effect among other NF-jB inhibitors 24 and can possibly be used as a sensitizer of anticancer therapy, 26, 27 increasing the intrinsic susceptibility of cancer cells to chemotherapeutic agents. 28 Evidence that inhibition of acidic bile-induced NF-jB activation effectively reverses the altered cancer-related miRNA phenotype will encourage the in vivo application of NF-jB inhibitors, as possible preventers of acidic bile effect in hypopharyngeal mucosa.
| MATERIALS AND METHODS
2.1 | Cell culture 2.1.1 | In vitro exposure to acidic bile with and without BAY 11-7082
Acidic bile treatment
We performed a repetitive exposure of human hypopharyngeal primary cells (HHPC) (2nd passage) (Celprogen Inc. CA, USA) and telomerase-immortalized human hypopharyngeal keratinocytes (HHK) (4th passage) 8 to bile (pH 4.0 and pH 7.0) and corresponding controls (pH 4.0 and pH 7.0), for 10-15 minutes, 3 times per day, for 5 days, as previously described. 8 Bile fluid consisted of a mixture of conjugated bile salts (400 lmol/L) considered to be "physiologic" 29, 30 (Supplementary Methods).
Experimental groups included HHPC and HHK repetitively exposed to (a) acidic bile at pH 4.0, the cut-off of reflux disease 31, 32 and (b) neutral bile, containing the same bile salts mixture, at pH 7.0.
Control groups included (a) acid control (pH 4.0), and (b) neutral control (pH 7.0) with identical media used in experimental groups (Supplementary Methods).
Acidic bile + BAY-11-7082 treatment
In parallel with acidic bile treatment, we performed an additional procedure of repetitive exposure of HHPC (2nd passage) and HHK At the end of treatment, media were removed and cells or cell extracts were analysed.
| Luciferase assay
We performed a luciferase assay in order to monitor the transcriptional activity of the NF-jB in HHPC exposed to acidic bile and corresponding controls, with or without the pharmacologic inhibitor of as ratios of relative NF-jB activity (with/without NF-jB inhibitor).
(Data were obtained from three independent experiments).
| miRNA analysis
We performed miRNA analysis in order to determine the expression levels of miR-21, -155, -192, -34a, -375 and -451a, previously characterized in laryngopharyngeal cancer, [12] [13] [14] [15] [16] [17] in normal human hypopharyngeal cells, HHPC and HHK, exposed to acidic bile (pH 4.0), neutral bile (pH 7.0), acid (pH 4.0) and neutral control (pH 7.0) fluids, with or without pharmacologic inhibitor BAY 11-7082. 11 We estimated relative expression levels (target miRNA/RNU6B) for each specific miRNA marker, in each experimental and control group treated with or without NF-jB inhibitor (CFX96TM software; Bio-Rad, CA, USA) (Supplementary Methods & Table S1 ). (Data were obtained from three independent experiments).
We used the same pool of total RNA to determine, by qPCR, the effect of BAY 11-7082 on transcriptional levels of RELA(p65), TNFa, IL-1b, IL-6 and STAT3 in acidic bile-treated and control HHPC with or without BAY 11-7082, as previously described 33 (Supplementary Methods & Table S2 ). These genes were selected because they demonstrated an increased transcriptional activity under acidic bile exposure of HHPC 8, 9 that was prevented by BAY 11-7082 in our previous study. 33 
| Immunofluorescence assay
We performed an immunofluorescence (IF) assay in HHPC, as previously described [8] [9] [10] (Supplementary Methods) to explore the effect of NF-jB inhibitor (20 lmol/L of BAY 11-7082) on the acidic bileinduced nuclear translocation of phospho-NF-jB (p65, Ser536) and phospho-STAT3 (Tyr705), previously shown to be up-regulated in 45-day acidic bile-treated murine laryngopharyngeal mucosa. 10 
| Cell viability assay
We performed a cell viability assay, using CellTiter-Glo â Luminescent Cell Viability Assay (Promega) to monitor the effect of NF-jB inhibitor, BAY 11-7082, on viability of HHPC and HHK treated with bile at pH 4.0 and pH 7.0, and corresponding controls, as described in Supplementary Methods. We determined cell viability by comparing the mean values of cells exposed to NF-jB inhibitor against the mean value of cells that were not exposed to inhibitor, for each experimental and control group. Statistically significant difference in cell viability was determined using paired test and P value <.05
(Graph Pad Prism 6.0).
| Statistical analysis
We performed statistical analysis, using GraphPad Human hypopharyngeal primary cells exposed to acidic bile with BAY 11-7082 demonstrated a significant decrease in "oncomirs" miR-21 (P = .006), miR-155 (P = .0035) and particularly of miR-192 levels (P < .00001) ( Figure 2B -a), as well as a significant increase in "tumour suppressor" miR-34a (P = .00023), miR-375 (P = .00134) and particularly of miR-451a levels (P < .000001) ( Figure 2B -b), compared to HHPC exposed to acidic bile without NF-jB inhibitor (t test analysis; multiple comparisons by Holm-Sidak). We also observed that HHPC exposed to acid with BAY 11-7082 demonstrated a significant decrease in miR-21 and miR-192 levels, compared to those exposed to acid without BAY 11-7082 (P = .038 and P = .007, respectively) (Figure 2B-a) (t test analysis; multiple comparisons by Holm-Sidak).
Similarly, HHK exposed to acidic bile with BAY 11-7082 exhibited a significant decrease in "oncomir" miR-21 levels (P = .001265), miR-155 (P = .002) and miR-192 (0.003) ( Figure 3B -a), as well as a significant increase in "tumour suppressor" miR-451a levels (P = .000339) and miR-375 (P < .0001) ( Figure 3B -b), compared to HHK exposed to acidic bile without NF-jB inhibitor (t test analysis; multiple comparisons by Holm-Sidak). We also observed that HHK exposed to neutral bile with BAY 11-7082 demonstrated a significant increase in miR-34a (P = .0012) and miR-451a (P = .0029) levels, relative to HHK expose to neutral bile without NF-jB inhibitor ( Figure 3B-b) . Finally, we observed that HHK exposed to acid with BAY 11-7082 showed a trending reduction, without statistical significance, in oncomirs miR-21 and miR-192, compared to HHK exposed to acid without BAY 11-7082 ( Figure 3B -a).
| NF-jB inhibitor induces a reversed
cancer-related miRNA phenotype in acidic bile-treated normal human hypopharyngeal cells, relative to controls
We observed that NF-jB inhibitor induced an inverted miRNA phenotype of "oncomirs" and particularly of "tumour suppressor" miRNAs in We further showed HHPC treated with acidic bile without BAY 11-7082 demonstrated a significantly higher miR-21/375 ratio, compared to neutral control or neutral bile, (P = .0022, and P = .0415, respectively, by Kruskal-Wallis) ( Figure 4B ), and similarly HHK treated with acidic bile without NF-jB inhibitor showed a significantly higher miR-21/375 ratio compared to neutral control or acid alone (P = .0022 and P = .0415, respectively, by Kruskal-Wallis). In contrast, we observed that BAY 11-7082 induced a significant reduction in miR-21/375 ratios in acidic bile-treated HHPC, compared to neutral control and neutral bile (P = .0022 and P = .0415, respectively) ( Figure 4C-b) , as well as in HHK, compared to neutral control and acid alone (P = .0022 and P = .0415, respectively) ( Figure 5C -b).
These observations suggest that NF-jB inhibition is capable of decreasing the acidic bile-induced elevated miR-21/375 ratios in both HHPC and HHK.
3.3 | BAY 11-7082 preferentially affects the acidic bile rather than the neutral bile-induced cancer-related miRNA phenotypes
We observed that miRNA changes induced by NF-jB inhibitor included a significant difference between acidic bile-(pH 4.0) and neutral bile (pH 7.0)-treated cells ( Figure S1 ). form of IL-6 up-regulation. 34 Our data from immunofluorescence assay demonstrated that the acidic bile-induced activated STAT3
and NF-jB were inhibited by NF-jB inhibitor in treated HHPC ( Figure 6 ). Specifically, we observed that acidic bile-treated HHPC showed an intense nuclear staining for both phospho-NF-jB (pp65 S556) ( Figure 6A ) and phospho-STAT3 (Tyr705) ( Figure 6B 
| DISCUSSION
Nuclear factor kappa B (NF-jB) is a key factor that mediates inflammatory and early tumorigenic events in epithelial cells, 35 and its importance in initiation and progression of cancer, including head and neck cancer, has been widely supported 23, [36] [37] [38] [39] [40] [41] by its interactions with a complex network of other cancer-related transcriptional factors, cytokines and growth factors. 34, [42] [43] [44] [45] [46] Additionally, Van Waes and Chen recently showed a cluster of genes and miRNA markers that are related to activated NF-jB and that may contribute to an aggressive phenotype of head and neck cancer.
23,38
Here, we present the first in vitro report that bile and acid com- Whereas the ratio of miR-21/375 has been considered a potential biomarker related to poor prognosis of supraglottic cancer, 13, 14 our data demonstrate a significant increase in miR-21/375 ratios in cells exposed to acidic bile (pH 4.0), compared to controls, a relationship that is effectively inverted in the presence of NF-jB inhibitor, again strongly supporting the miR-21/375 ratio, as a potential biomarker in acidic bile-induced cancer-related molecular events in hypopharyngeal cells, mediated by NF-jB pathway.
Our novel findings also demonstrate that NF-jB inhibition significantly prevents the acidic bile-induced up-regulation of miR-155.
Gerloff et al showed that NF-jB can up-regulate miR-155 by binding on its promoter. 51 Others have shown that constitutive up-regulation of miR-155 may mediate prolonged inflammatory reactions leading to cancer. 18, 52 We previously showed a significant up-regulation of miR-155 in laryngopharyngeal mucosa treated by acidic bile accompanied by pre-neoplastic lesions. 10 Our current findings also demonstrate that miR-451a could be an important marker of acidic bile-related laryngopharyngeal carcinogenesis, in agreement with Fukumoto et al who previously suggested miR-451a is a tumour suppressor marker in hypopharyngeal SCC. 55 This in vitro measure is in line with our 45-day in vivo model where a significant down-regulation of miR-451a occurred. 10 We also showed a significant effect of NF-jB inhibition on "tu- | 2931 suppressor and key regulator miRNA in HNSCC, 17, 23 and our prior in vivo findings showed that acidic bile down-regulated miR-34a levels in treated laryngopharyngeal mucosa. Although previous studies reported NF-jB binding sites on the promoter of miR-34a, 21, 56 and an increase in miR-34a levels in oesophageal cells under NF-jB activation, 21 the exact mechanism of miR-34a regulation by NF-jB is not yet obvious. Alternatively, it has been shown that STAT3 can directly repress miR-34a, while an active IL-6R/STAT3/miR-34a loop was found necessary for EMT, invasion and metastasis of colorectal cancer cell line. 56 Our current data support the notion that NF-jB inhibition is capable of preventing down-regulation of miR-34a by acidic bile.
As would be expected, the individual response of HHPC and HHK was not always congruent. The ability of BAY 11-7082 to reverse acidic bile-induced phenotype of "oncomir" miR-192 was more prominent in HHPC compared to HHK. Likewise, the effect of NF-jB inhibition regarding "tumour suppressor" miRNAs miR-34a
and miR-451a was more intense in HHPC relative to HHK under acidic bile exposure. We are of the understanding that effects may be related to differences in maturational status. Primary cells HHPC, considered to be less mature and more sensitive to injurious external stimuli than immortalized keratinocytes HHK, may respond differently to NF-jB inhibition. The miRNA phenotype observed in HHPC was in fact similar to that observed in vivo, an observation in support of this view. Similarly, bile at neutral pH seemed to contribute to deregulations of "tumour suppressor" miRNAs, such as miR-34a and miR-451a, but was not capable of accelerating activation of oncogenic STAT3 or other cancer-related molecules. Our data support the observation that acid and bile in combination but not acid or bile alone may contribute to cancer-related molecular events, mediated by NF-jB.
Our findings revealed that NF-jB inhibition resulted in a significant reduction in viable cells, particularly in acidic bile-treated groups. The identified decreased cell viability induced by 7082 is in line with previous studies. 27 The preferential effect of BAY 11-7082 in acidic bile-treated groups is especially interesting because it suggests its effect on cell viability is not global but related to specific events, in those groups. Interestingly, other studies have
shown that increased expression of miR-34a and miR-375 reduces cell viability of cancer cell lines. 57, 58 In this regard, our present data also showed that BAY 11-7082 decreases the levels of "oncomirs", miR-155, miR-192 and miR-21 levels, while increasing the levels of "tumour suppressors", miR-34a and miR-375, raising the view that specific cancer-related miRNAs interactions may be at least partially responsible for decreased cells viability. and -451a in treated hypopharyngeal mucosa.
| CONCLUSION
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